Table 2.
Study | Design of study | Comparative intervention | Patients (n) | Tumours (n) | Mean tumour size or range on preoperative (cm) | Tumour type Exophytic Parenchymal, xcentral, mixed or others | Laparoscopic or Percutaneous Cryoablation | Follow-up (months) | |
---|---|---|---|---|---|---|---|---|---|
Atwell 200833 | Retrospective | N/A | 110 | 115 | 3.3 | 56 | 59 | Percutaneous | 13.3b |
Finley 200834 | Retrospective | N/A | 37 | 43 | 2.9 | 6 | 36 | Percutaneous and laparoscopic | 12.8b |
Georgiades 200835 | Case series | N/A | 46 | 40 | 3.0c | NR | Percutaneous | 28c | |
Hinshaw 200836 | Retrospective | N/A | 90 | 90 | Perc. 2.1 Lap. 2.5 |
NR | Percutaneous and laparoscopic | Perc. 14.5b Lap. 16.5b |
|
Lehman 200837 | Retrospective | N/A | 44 | 51 | Group 1d 1.8 Group 2d 4.0 |
32 | 19 | Laparoscopic | Group 1:9.0b Group 2: 11.0b |
Nguyen 200838 | Retrospective comparative | RFA | CA 14 RFA 22 |
CA 25 RFA 38 |
CA 3.0 RFA 2.8 |
NR | Laparoscopic and open | NR | |
Weight 200839 | Retrospective comparative | RFA | CA 176 RFA 88 |
CA 192 RFA 109 |
CA 2.4 RFA 2.5 |
NR CA 30 NR RFA 42 |
Laparoscopic | 6 | |
Atwell 2007a,b39–41 | Retrospective | N/A | 40 | 40 | 4.2 | 15 | 25 | Percutaneous | 9b |
Bandi 200742 | Retrospective | N/A | 78 | 88 | 2.6 | NR | Percutaneous and laparoscopic | 19b | |
Cestari 200743 | Retrospective | N/A | 86 | 56 | 2.3 | NR | Laparoscopic | 24 | |
Littrup 200744 | Retrospective | N/A | 48 | 49 | 3.3 | 30 | 19 | Percutaneous | 1.1c |
Lokken 200730 | Retrospective comparative | RFA | 253 | 287 | 3.0 | NR | Percutaneous | 52 | |
Weld 200745 | Case series | N/A | 31 | 36 | 2.1 | 27 | 09 | Laparoscopic | 45.7b |
Wright 200729 | Retrospective | N/A | 32 | 35 | 1.9 | 32 | 03 | Laparoscopic | 18c |
Davol 200646 | Retrospective | N/A | 48 | 48 | 2.6 | 44 | 04 | Laparoscopic and open | 64b |
Hegarty 200647 | Retrospective comparative | RFA | CA 161 RFA 72 |
CA 179 RFA 81 |
CA 2.56 RFA 2.51 |
NR NR |
CA 6% RFA 37% |
Laparoscopic | CA 36c RFA 13c |
Lawatsch 200648 | Case series | N/A | 59 | 81 | 2.5 | NR | Laparoscopic | 26.8c | |
Matin 200649 | Retrospective comparative | RFA | CA 8f RFA 55f |
N | 3.85 | 39% | 61% | Percutaneous and laparoscopic | 24.2b |
Schwartz 200650 | Retrospective | N/A | 84 | 85 | 2.6 | NR | Laparoscopic and open | 10b | |
Desai 200551 | Retrospective comparative | LPN | CA 78 LPN 153 |
CA 89 LPN 153 |
CA 2.05 LPN 2.25 |
NR | Laparoscopic | CA 24.6b LPN 5.8b |
|
Gill 200527 | Case series | N/A | 56 | 60 | 2.3 | NR | Laparoscopic | 36 | |
Cestari 200452 | Case series | N/A | 37 | NR | 2.5 | NR | Laparoscopic | 20.5b | |
Gill 200053 | Case series | N/A | 32 | 34 | 2.3 | NR | Laparoscopic | 12 |
RFA: Radiofrequency ablation; LPN: Laparoscopic partial nephrectomy; CA: cryoablation; N/A: not applicable; NR: not reported.
A subset of these patients have been included in 2 prior publications (Atwell 2007a and Atwell 2007b);
Mean;
Mean;
In Group 1 the patients presented with a maximum tumour diameter less than 3.0 cm and, group 2 patients had a maximum tumour diameter of 3.0 cm or larger;
Atwell 2007 has two publications with the same participants;
Patients with residual or recurrent disease.